Bruck K, Stel VS, Gambaro G, Hallan S, Volzke H, Arnlov J, et al. CKD prevalence varies across the european general population. J Am Soc Nephrol. 2016;27:2135–47.

Article  PubMed  Google Scholar 

Levin A, Tonelli M, Bonventre J, Coresh J, Donner JA, Fogo AB, et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017;390:1888–917.

Article  PubMed  Google Scholar 

Thomas B, Matsushita K, Abate KH, Al-Aly Z, Arnlov J, Asayama K, et al. Global cardiovascular and renal outcomes of reduced GFR. J Am Soc Nephrol. 2017;28:2167–79.

CAS  PubMed Central  Article  PubMed  Google Scholar 

Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One. 2016;11:e0158765.

PubMed Central  Article  CAS  PubMed  Google Scholar 

Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transpl. 1996;11:1277–85.

CAS  Article  Google Scholar 

Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–23.

Article  PubMed  Google Scholar 

Bromfield S, Muntner P. High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs. Curr Hypertens Rep. 2013;15:134–6.

PubMed Central  Article  PubMed  Google Scholar 

Muntner P, Anderson A, Charleston J, Chen Z, Ford V, Makos G, et al. Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2010;55:441–51.

CAS  Article  PubMed  Google Scholar 

Kestenbaum B, Rudser KD, de Boer IH, Peralta CA, Fried LF, Shlipak MG, et al. Differences in kidney function and incident hypertension: the multi-ethnic study of atherosclerosis. Ann Intern Med. 2008;148:501–8.

PubMed Central  Article  PubMed  Google Scholar 

Bidani AK, Griffin KA. Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension. 2004;44:595–601.

CAS  Article  PubMed  Google Scholar 

Brantsma AH, Bakker SJ, de Zeeuw D, de Jong PE, Gansevoort RT. Urinary albumin excretion as a predictor of the development of hypertension in the general population. J Am Soc Nephrol. 2006;17:331–5.

CAS  Article  PubMed  Google Scholar 

Chue CD, Townend JN, Steeds RP, Ferro CJ. Arterial stiffness in chronic kidney disease: causes and consequences. Heart. 2010;96:817–23.

Article  PubMed  Google Scholar 

Moody WE, Edwards NC, Chue CD, Ferro CJ, Townend JN. Arterial disease in chronic kidney disease. Heart. 2013;99:365–72.

CAS  Article  PubMed  Google Scholar 

Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl J Med. 2004;351:1296–305.

CAS  Article  PubMed  Google Scholar 

Aoki J, Ikari Y, Nakajima H, Mori M, Sugimoto T, Hatori M, et al. Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients. Kidney Int. 2005;67:333–40.

Article  PubMed  Google Scholar 

Chronic Kidney Disease Prognosis C, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375:2073–81.

Article  Google Scholar 

Steenkamp R, Rao A, Roderick P. UK renal registry 17th annual report: chapter 5 survival and cause of death in UK adult patients on renal replacement therapy in 2013: National and Centre-specific Analyses. Nephron 2015;129:99–129.

Article  PubMed  Google Scholar 

U.S. Renal Data System. USRDS 2015 annual data report: atlas of end-stage renal disease in the United States. Bethseda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2015.

Wanner C, Amann K, Shoji T. The heart and vascular system in dialysis. Lancet. 2016;388:276–84.

Article  PubMed  Google Scholar 

Kalra PA, Green D, Poulikakos D. Arrhythmia in hemodialysis patients and its relation to sudden death. Kidney Int. 2018;93:781–3.

Article  PubMed  Google Scholar 

Saran R, Robinson B, Abbott KC, Agodoa LY, Albertus P, Ayanian J, et al. US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2017;69:A7–A8.

PubMed Central  Article  PubMed  Google Scholar 

Methven S, Steenkamp R, Fraser S. UK Renal Registry 19th Annual Report: Chapter 5 Survival and Causes of Death in UK Adult Patients on Renal Replacement Therapy in 2015: National and Centre-specific Analyses. Nephron. 2017;137:117–50.

Article  PubMed  Google Scholar 

Thompson S, James M, Wiebe N, Hemmelgarn B, Manns B, Klarenbach S, et al. Cause of death in patients with reduced kidney function. J Am Soc Nephrol. 2015;26:2504–11.

PubMed Central  Article  PubMed  Google Scholar 

Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011;377:2181–92.

CAS  PubMed Central  Article  PubMed  Google Scholar 

Tonelli M, Isles C, Curhan GC, Tonkin A, Pfeffer MA, Shepherd J, et al. Effect of pravastatin on cardiovascular events in people with chronic kidney disease. Circulation. 2004;110:1557–63.

CAS  Article  PubMed  Google Scholar 

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, et al. Lipid management in patients with chronic kidney disease. Nat Rev Nephrol. 2018;14:727–49.

CAS  Article  PubMed  Google Scholar 

Wanner C, Krane V, Marz W, Olschewski M, Asmus HG, Kramer W, et al. Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics. Kidney Blood Press Res. 2004;27:259–66.

CAS  Article  PubMed  Google Scholar 

Fellstrom BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009;360:1395–407.

CAS  Article  PubMed  Google Scholar 

Drueke T, Le Pailleur C, Zingraff J, Jungers P. Uremic cardiomyopathy and pericarditis. Adv Nephrol Necker Hosp. 1980;9:33–70.

CAS  PubMed  Google Scholar 

Hung J, Harris PJ, Uren RF, Tiller DJ, Kelly DT. Uremic cardiomyopathy-effect of hemodialysis on left ventricular function in end-stage renal failure. N Engl J Med. 1980;302:547–51.

CAS  Article  PubMed  Google Scholar 

Mall G, Huther W, Schneider J, Lundin P, Ritz E. Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transpl. 1990;5:39–44.

CAS  Article  Google Scholar 

Hayer MK, Price AM, Liu B, Baig S, Ferro CJ, Townend JN, et al. Diffuse myocardial interstitial fibrosis and dysfunction in early chronic kidney disease. Am J Cardiol. 2018;121:656–60.

PubMed Central  Article  PubMed  Google Scholar 

Rutherford E, Talle MA, Mangion K, Bell E, Rauhalammi SM, Roditi G, et al. Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping. Kidney Int. 2016;90:845–52.

PubMed Central  Article  PubMed  Google Scholar 

Graham-Brown MP, March DS, Churchward DR, Stensel DJ, Singh A, Arnold R, et al. Novel cardiac nuclear magnetic resonance method for noninvasive assessment of myocardial fibrosis in hemodialysis patients. Kidney Int. 2016;90:835–44.

Article  PubMed  Google Scholar 

Edwards NC, Moody WE, Yuan M, Hayer MK, Ferro CJ, Townend JN, et al. Diffuse interstitial fibrosis and myocardial dysfunction in early chronic kidney disease. Am J Cardiol. 2015;115:1311–7.

Article  PubMed  Google Scholar 

Mark PB, Johnston N, Groenning BA, Foster JE, Blyth KG, Martin TN, et al. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int. 2006;69:1839–45.

CAS  Article  PubMed  Google Scholar 

Chen L, Kuang P, Liu H, Wei Q, Cui H, Fang J, et al. Sodium fluoride (NaF) induces inflammatory responses via activating MAPKs/NF-kappab signaling pathway and reducing anti-inflammatory cytokine expression in the mouse liver. Biol Trace Elem Res. 2019;189:157–71.

CAS  Article  PubMed  Google Scholar 

Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47:186–92.

CAS  Article  PubMed  Google Scholar 

Parfrey PS, Harnett JD, Griffiths SM, Taylor R, Hand J, King A, et al. The clinical course of left ventricular hypertrophy in dialysis patients. Nephron. 1990;55:114–20.

CAS  Article  PubMed  Google Scholar 

Edwards NC, Moody WE, Chue CD, Ferro CJ, Townend JN, Steeds RP. Defining the natural history of uremic cardiomyopathy in chronic kidney disease: the role of cardiovascular magnetic resonance. JACC Cardiovasc Imaging. 2014;7:703–14.

Article